Researchers have developed a composite double-network hydrogel that adheres to soft tissues such as cartilage and the meniscus, according to an article in ACS Applied Materials & Interfaces.

SurGenTec completed the initial clinical launch of its new GraftGun bone graft delivery system combined with Aziyo Biologics’ ViBone Viable Bone Matrix prefilled tubes for minimally invasive spine surgery. 

ORTHOReBIRTH USA and Altamonte Springs, Fla.-based Adventist Health System Sunbelt Healthcare Corp. entered into a product agreement.

Spinal device company Innovasis partnered with Stability Biologics to enter the biologics market.

The FDA warned StemGenex Biologic Laboratories about illegally marketing an unapproved stem cell product produced in a facility with significant manufacturing violations, putting patients at risk.

CollPlant is a regenerative medicine company focused on 3D bioprinting tissues and organs and developing orthobiologics.

SpinalCyte reported positive 12-month endpoint MRI outcomes in a clinical study of its CybroCell injection for degenerative disc disease.

Tel Aviv (Israel) University researchers generated functional spinal cord, cardiac, cortical and adipogenic tissue implants from personalized hydrogels, according to results detailed in Advanced Materials.

Cellect Biotechnology is a regenerative medicine company.

Bio2 Technologies received FDA approval to begin enrolling patients in an investigational device exemption clinical study to evaluate Vitrium as a cervical interbody fusion device.

Joost de Bruijn, PhD, is the CEO of Kuros Biosciences.

Histogenics develops restorative cell therapies for orthopedic pain relief.

Imagion Biosystems is commercializing a form of medical imaging that uses biosafe nanoparticles to detect cancer, according to Proactive Investors Australia.

Regenerative medicine company SpinalCyte was issued new patents in Hong Kong and Europe.

Guy Cook is the CEO of Lattice Biologics.

Cellect Biotechnology received several patent grants for its Apograft technology.

OsteoRemedies launched the first FDA-cleared dual-antibiotic spacer system and bone cement offering with gentamicin and vancomycin.  

MTF Biologics and Academy Medical partnered to bring human allograft tissues to Veteran Affairs medical centers across the U.S.

ORTHOReBIRTH USA signed a letter of intent to develop new biologic products with Loubert Suddaby, MD.

The Tobra Medical Bone Basket is designed to help surgeons maximize the collection of autologous bone during drilling for bone graft.